Freshworks (FRSH) 10-Q 4 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 28, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-40806
Entity Registrant Name	Freshworks Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2950 S Delaware Street
Entity Address, Address Line Two	Suite 201
Entity Address, City or Town	San Mateo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94403
Entity Tax Identification Number	33-1218825
City Area Code	650
Local Phone Number	513-0514
Title of 12(b) Security	Class A common stock, par value $0.00001 per share
Trading Symbol	FRSH
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001544522
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		161,102,744
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		126,814,106

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 432,313	$ 747,861
Marketable securities	719,218	575,679
Accounts receivable, net of allowance of $5,500 and $6,030	56,835	51,756
Deferred contract acquisition costs	18,282	14,640
Prepaid expenses and other current assets	42,431	31,440
Total current assets	1,269,079	1,421,376
Property and equipment, net	23,381	21,478
Operating lease right-of-use assets	28,821
Deferred contract acquisition costs, noncurrent	17,598	15,007
Intangible assets, net	579	1,894
Goodwill	6,181	6,181
Deferred tax assets	5,396	6,284
Other assets	12,050	10,592
Total assets	1,363,085	1,482,812
Current liabilities:
Accounts payable	3,873	6,321
Accrued liabilities	57,447	55,829
Deferred revenue	190,969	160,173
Income tax payable	65	1,023
Total current liabilities	252,354	223,346
Operating lease liabilities, non-current	24,630
Other liabilities	26,098	21,427
Total liabilities	303,082	244,773
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred Stock, value	0	0
Additional paid-in capital	4,516,386	4,509,724
Accumulated other comprehensive loss	(8,790)	(747)
Accumulated deficit	(3,447,596)	(3,270,941)
Total stockholders' equity	1,060,003	1,238,039
Total liabilities and stockholders' equity	1,363,085	1,482,812
Class A Common Stock
Stockholders' equity:
Common stock, value	2	0
Class B Common Stock
Stockholders' equity:
Common stock, value	$ 1	$ 3

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts receivable, allowance for credit loss, current	$ 5,500	$ 6,030
Preferred stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	150,644,801	50,554,821
Common stock, outstanding (in shares)	150,644,801	50,554,821
Class B Common Stock
Common stock, par value (in USD per share)	$ 0.00001	$ 0.00001
Common stock, authorized (in shares)	350,000,000	350,000,000
Common stock, issued (in shares)	136,437,496	222,739,562
Common stock, outstanding (in shares)	136,437,496	222,739,562

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 128,760	$ 96,614	$ 364,829	$ 265,542
Cost of revenue	24,179	22,236	70,616	57,632
Gross profit	104,581	74,378	294,213	207,910
Operating expense:
Research and development	35,871	57,087	100,885	91,377
Sales and marketing	86,865	96,785	248,369	188,155
General and administrative	40,133	60,759	117,723	76,785
Total operating expenses	162,869	214,631	466,977	356,317
Loss from operations	(58,288)	(140,253)	(172,764)	(148,407)
Interest and other income, net	2,249	22,923	2,609	23,428
Loss before income taxes	(56,039)	(117,330)	(170,155)	(124,979)
Provision for (benefit from) income taxes	1,804	(9,915)	6,500	(7,720)
Net loss	(57,843)	(107,415)	(176,655)	(117,259)
Decretion of redeemable convertible preferred stock	0	(2,264,838)	0	(2,646,662)
Net income (loss) available to common stockholders, basic, total	(57,843)	(2,372,253)	(176,655)	(2,763,921)
Net income (loss) available to common stockholders, diluted, total	$ (57,843)	$ (2,372,253)	$ (176,655)	$ (2,763,921)
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	$ (0.20)	$ (24.72)	$ (0.62)	$ (32.96)
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	$ (0.20)	$ (24.72)	$ (0.62)	$ (32.96)
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares)	286,697	95,930	283,258	83,860
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares)	286,697	95,930	283,258	83,860

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (57,843)	$ (107,415)	$ (176,655)	$ (117,259)
Other comprehensive loss:
Unrealized loss on marketable securities	(2,481)	(18)	(8,043)	(431)
Comprehensive loss	$ (60,324)	$ (107,433)	$ (184,698)	$ (117,690)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020	153,938,000
Beginning balance at Dec. 31, 2020	$ 2,895,096
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of redeemable convertible preferred stock (in shares)	$ 2,646,662
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)	(153,938,000)
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)	$ (5,541,758)
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020		77,619,000
Beginning balance at Dec. 31, 2020	(2,696,741)	$ 1	$ 0	$ 411	$ (2,697,153)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of redeemable convertible preferred stock	(2,646,662)		(2,264,869)		(381,793)
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)		153,938,000
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	5,541,758	$ 2	5,541,756
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses (in shares)		31,350,000
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses	1,062,453		1,062,453
Issuance of common stock upon exercise of stock options (in shares)		210,000
Issuance of common stock upon exercise of stock options	43		43
Stock-based compensation	124,717		124,717
Unrealized loss on marketable securities	(431)			(431)
Net loss	(117,259)				(117,259)
Ending balance (in shares) at Sep. 30, 2021		263,117,000
Ending balance at Sep. 30, 2021	$ 1,267,878	$ 3	4,464,100	(20)	(3,196,205)
Beginning balance (in shares) at Jun. 30, 2021	153,938,000
Beginning balance at Jun. 30, 2021	$ 3,276,920
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of redeemable convertible preferred stock (in shares)	$ 2,264,838
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)	(153,938,000)
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)	$ (5,541,758)
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Beginning balance (in shares) at Jun. 30, 2021		77,756,000
Beginning balance at Jun. 30, 2021	(3,088,791)	$ 1		(2)	(3,088,790)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of redeemable convertible preferred stock	(2,264,838)		(2,264,838)
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares)		153,937,730
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	5,541,758	$ 2	5,541,756
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses (in shares)		31,350,000
Issuance of common stock upon initial public offering, net of underwriting discount and offering expenses	1,062,453		1,062,453
Issuance of common stock upon exercise of stock options (in shares)		73,000
Issuance of common stock upon exercise of stock options	12		12
Stock-based compensation	124,717		124,717
Unrealized loss on marketable securities	(18)			(18)
Net loss	(107,415)				(107,415)
Ending balance (in shares) at Sep. 30, 2021		263,117,000
Ending balance at Sep. 30, 2021	$ 1,267,878	$ 3	4,464,100	(20)	(3,196,205)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021		273,294,000
Beginning balance at Dec. 31, 2021	$ 1,238,039	$ 3	4,509,724	(747)	(3,270,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	383,000	389,000
Issuance of common stock upon exercise of stock options	$ 106		106
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		12,889,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	$ (152,330)		(152,330)
Issuance of common stock under employee stock purchase plan, net of shares withheld for taxes (in shares)	510,093	510,000
Issuance of common stock under employee stock purchase plan, net of shares withheld and retired for taxes	$ 6,959		6,959
Stock-based compensation	151,927		151,927
Unrealized loss on marketable securities	(8,043)			(8,043)
Net loss	(176,655)				(176,655)
Ending balance (in shares) at Sep. 30, 2022		287,082,000
Ending balance at Sep. 30, 2022	$ 1,060,003	$ 3	4,516,386	(8,790)	(3,447,596)
Beginning balance (in shares) at Jun. 30, 2022	0
Beginning balance at Jun. 30, 2022	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Jun. 30, 2022		285,558,000
Beginning balance at Jun. 30, 2022	1,079,610	$ 3	4,475,669	(6,309)	(3,389,753)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		34,000
Issuance of common stock upon exercise of stock options	3		3
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,490,000
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(13,230)		(13,230)
Stock-based compensation	53,944		53,944
Unrealized loss on marketable securities	(2,481)			(2,481)
Net loss	(57,843)				(57,843)
Ending balance (in shares) at Sep. 30, 2022		287,082,000
Ending balance at Sep. 30, 2022	$ 1,060,003	$ 3	$ 4,516,386	$ (8,790)	$ (3,447,596)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (57,843)	$ (176,655)	$ (117,259)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization		8,574	9,792
Amortization of deferred contract acquisition costs	4,625	13,321	9,085
Non-cash lease expense		4,463
Stock-based compensation		150,652	124,259
Premium amortization on marketable securities		564	1,206
Gain realized on sale of marketable securities and non-marketable equity investment		0	(23,835)
Change in fair value of equity securities		(75)	(100)
Deferred income taxes		309	(11,721)
Other		1,468	133
Changes in operating assets and liabilities:
Accounts receivable		(5,256)	(10,039)
Deferred contract acquisition costs		(19,554)	(17,032)
Prepaid expenses and other assets		(12,374)	(14,823)
Accounts payable		(1,962)	(542)
Accrued and other liabilities		3,874	18,517
Deferred revenue		30,796	38,975
Operating lease liabilities		(7,837)
Net cash (used in) provided by operating activities		(9,692)	6,616
Cash Flows from Investing Activities:
Purchases of property and equipment		(5,288)	(4,056)
Proceeds from sale of property and equipment		132	565
Capitalized internal-use software		(3,828)	(3,050)
Sale of non-marketable equity investment		0	23,979
Purchases of marketable securities		(538,501)	(154,828)
Sales of marketable securities		92,786	36,831
Maturities and redemptions of marketable securities		293,625	112,554
Net cash (used in) provided by investing activities		(161,074)	11,995
Cash Flows from Financing Activities:
Proceeds from initial public offering, net of underwriting discounts		0	1,069,348
Proceeds from issuance of common stock under employee stock purchase plan, net		7,011	0
Proceeds from exercise of stock options		98	43
Payment of withholding taxes on net share settlement of equity awards		(151,716)	0
Payment of deferred offering costs		(109)	(5,472)
Payment of acquisition-related liabilities		0	(900)
Net cash (used in) provided by financing activities		(144,716)	1,063,019
Net (decrease) increase in cash, cash equivalents and restricted cash		(315,482)	1,081,630
Cash, cash equivalents and restricted cash, beginning of period		747,864	98,331
Cash, cash equivalents and restricted cash, end of period	432,382	432,382	1,179,961
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets:
Cash and cash equivalents	432,313	432,313	1,179,958
Restricted cash included in prepaid expenses and other current assets	3	3	0
Restricted cash included in other assets	66	66	3
Total cash, cash equivalents and restricted cash	432,382	432,382	1,179,961
Supplemental cash flow information:
Cash paid for taxes		9,550	6,981
Non-cash investing and financing activities:
Operating lease right-of-use assets obtained in exchange for operating lease obligations	1,749	8,968	0
Stock-based compensation capitalized as internal-use software	52	1,275	458
Deferred offering costs		0	1,423
Accretion of redeemable convertible preferred stock	$ 0	$ 0	$ 2,646,662

Business, Basis of Presentation

Business, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business, Basis of Presentation and Summary of Significant Accounting Policies	Business, Basis of Presentation and Summary of Significant Accounting Policies Description of business Freshworks Inc. (Freshworks, or the Company) is a software development company that provides modern software-as-a-service (SaaS) products that are designed with the user in mind. The Company was incorporated in Delaware in 2010 and is headquartered in San Mateo, California. In September 2021, the Company completed its initial public offering (IPO), in which it issued and sold 31,350,000 shares of its newly authorized Class A common stock at $36.00 per share. The Company received proceeds of approximately $1.1 billion from the IPO, net of underwriters’ discounts and offering expenses. Upon completion of the IPO, certain shares of Class B common stock then outstanding (excluding shares of Class B common stock issued upon conversion and reclassification of the redeemable convertible preferred stock described below) were automatically converted to Class A common stock on a one-to-one basis, unless an option to remain as Class B common stock was elected by the holder. In addition, all shares of redeemable convertible preferred stock then outstanding were converted into 153,937,730 shares of common stock on a one-to-one basis and then reclassified into Class B common stock. Upon the Company's IPO, the liquidity event condition was met for all restricted stock units (RSUs). RSUs that had already met the service condition at that date were entitled to one share of Class B common stock for each vested RSU. In September 2021, the Company also completed a 10-for-one forward stock split of the Company's authorized, issued and outstanding stock. All share and per share information included in the accompanying condensed consolidated financial statements and notes thereto have been adjusted on a retrospective basis to reflect the stock split. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Unaudited Interim Consolidated Financial Statement s The accompanying condensed consolidated balance sheet as of September 30, 2022, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of redeemable convertible preferred stock and stockholders’ equity (deficit) for the three and nine months ended September 30, 2022 and 2021, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2022 and its results of operations and cash flows for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 23, 2022. Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases. Risk and Uncertainties The COVID-19 pandemic has already had an adverse effect on the global economy and the ultimate societal and economic impact thereof still remains uncertain. Additionally, inflationary pressures, significant volatility in the global markets and geopolitical conflicts have also led to further economic disruption. These macroeconomic uncertainties could adversely affect demand for the Company’s products and services, lead to longer sales cycles, reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of the existing customers to go out of business, not expand or grow their businesses and affect contraction or attrition rates of the Company’s customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. The Company is not aware of any specific event or circumstances related to the pandemic, or other events that would require it to update estimates or judgments or adjust the carrying value of its assets or liabilities. Actual results could differ from those estimates and any such differences may be material to the consolidated financial statements. Concentrations of Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three and nine months ended September 30, 2022 and 2021 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of September 30, 2022. The Company primarily relies upon its third-party cloud infrastructure partner, Amazon Web Services, to serve customers and operate certain aspects of its services. Any disruption of this cloud infrastructure partner would impact the Company's operations and its business could be adversely impacted. Significant Accounting Policies The Company's significant accounting policies are described in the Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes to these policies that have had a material impact on the condensed consolidated financial statements and the related notes for the three and nine months ended September 30, 2022, with the exception of the adoption of Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842) as described below. See also Recently Adopted Accounting Pronouncements for more detail on the adoption. Leases The Company leases office space under operating leases with expiration dates through 2031. The Company determines whether an arrangement constitutes a lease and records lease liabilities and right-of-use (ROU) assets on its condensed consolidated balance sheets at the lease commencement date. Lease liabilities are measured based on the present value of the total lease payments not yet paid, discounted based on either the rate implicit in the lease or the Company's incremental borrowing rate (the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease), whichever is more readily determinable. Lease liabilities due within 12 months are included within accrued liabilities on the Company's condensed consolidated balance sheets. The incremental borrowing rate is based on an estimate of the Company's expected unsecured borrowing rate for its notes, adjusted for tenor and collateralized security features. ROU assets are measured based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the lease commencement date, (ii) initial direct costs incurred, and (iii) tenant incentives received, incurred or payable under the lease. Recognition of rent expense begins when the lessor makes the underlying asset available to the Company. The Company does not assume renewals or early terminations of its leases unless it is reasonably certain to exercise these options at commencement and does not allocate consideration between lease and non-lease components. For short-term leases, the Company records rent expense in its condensed consolidated statements of operations on a straight-line basis over the lease term and records variable lease payments as incurred. Recent Accounting Pronouncements New accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) under its Accounting Standards Codification (ASC) or ASU and adopted by the Company as of the specified effective date. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize most leases on their balance sheets as ROU assets with corresponding lease liabilities and eliminates certain real estate-specific provisions. The Company adopted this standard effective January 1, 2022 on a modified retrospective basis, and as such, results in comparative periods were not restated. As a result of the adoption, the Company recognized operating ROU assets of $24.3 million and operating lease liabilities of $28.8 million in its condensed consolidated balance sheets on the adoption date. The Company has elected certain available practical expedients, which allow it to forego the reassessments of (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. The Company has also elected to combine lease and non-lease components for commercial lease arrangements. Additionally, the Company elected not to recognize operating ROU assets and the associated operating lease liabilities for leases with a term of 12 months or less from the lease commencement date. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets by requiring an allowance to be recorded as an offset to the amortized cost of such assets. The standard primarily impacts the amortized cost of the Company's available-for-sale debt securities. The Company adopted this standard on January 1, 2022 using the modified retrospective approach, which did not result in a material impact on its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The standard eliminates certain exceptions related to the approach for intraperiod tax allocation and the methodology for calculating income taxes in an interim period. The standard also simplifies aspects of accounting for franchise taxes and enacted changes in tax or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis for goodwill. The Company adopted this standard effective January 1, 2022, which did not result in a material impact on its condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. ASU 2021-08 will become effective for the Company on January 1, 2023, to be applied prospectively to business combinations occurring on or after the effective date of the ASU, with early adoption permitted. The Company adopted this standard effective January 1, 2022, which did not result in a material impact on its condensed consolidated financial statements.

Revenue From Contracts with Cus

Revenue From Contracts with Customers	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue From Contracts with Customers	Revenue From Contracts with Customers Revenue The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes. Disaggregation of Revenue The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Subscription services $ 125,508 $ 94,312 $ 355,298 $ 257,827 Professional services 3,252 2,302 9,531 7,715 Total revenue $ 128,760 $ 96,614 $ 364,829 $ 265,542 See Note 12 for revenue by geographic location. Deferred Revenue and Remaining Performance Obligations Deferred revenue consists of customer billings in advance of revenue being recognized from the Company’s subscription and professional services arrangements. Revenue recognized during the three months ended September 30, 2022 and 2021 from amounts included in deferred revenue at the beginning of these periods was $86.2 million and $61.6 million, respectively. Revenue recognized during the nine months ended September 30, 2022 and 2021 from amounts included in deferred revenue at the beginning of these periods was $146.9 million and $95.6 million, respectively. The aggregate balance of remaining performance obligations as of September 30, 2022 was $277.4 million. The Company expects to recognize $218.7 million of the balance as revenue in the next 12 months and the remainder thereafter. The aggregate balance of remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Deferred Contract Acquisition Costs The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Balance at beginning of the period $ 33,592 $ 23,604 $ 29,647 $ 18,273 Add: Contract costs capitalized during the period 6,913 6,032 19,554 17,032 Less: Amortization of contract costs during the period (4,625) (3,416) (13,321) (9,085) Balance at end of the period $ 35,880 $ 26,220 $ 35,880 $ 26,220

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	9 Months Ended
	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities Cash equivalents and available-for-sale debt securities consisted of the following as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 266,193 $ — $ — $ 266,193 U.S. treasury securities 44,363 4 — 44,367 U.S. government agency securities 80,225 14 (1) 80,238 Corporate debt securities 4,889 — — 4,889 Total cash equivalents 395,670 18 (1) 395,687 Debt securities: U.S. treasury securities 421,677 11 (4,434) 417,254 U.S. government agency securities 201,499 1 (3,277) 198,223 Corporate debt securities 103,358 — (1,108) 102,250 Total debt securities 726,534 12 (8,819) 717,727 Total cash equivalents and debt securities $ 1,122,204 $ 30 $ (8,820) $ 1,113,414 December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 684,485 $ — $ — $ 684,485 U.S. treasury securities 22,000 — — 22,000 U.S. government agency securities 4,286 — (1) 4,285 Corporate debt securities 15,998 — — 15,998 Total cash equivalents 726,769 — (1) 726,768 Debt securities: U.S. treasury securities 442,715 2 (432) 442,285 U.S. government agency securities 75,725 — (159) 75,566 Corporate debt securities 54,335 17 (175) 54,177 Total debt securities 572,775 19 (766) 572,028 Total cash equivalents and debt securities $ 1,299,544 $ 19 $ (767) $ 1,298,796 The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of September 30, 2022 (in thousands): September 30, 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 361,963 $ (4,316) $ 8,885 $ (118) $ 370,848 $ (4,434) U.S. government agency securities 196,721 (3,277) — — 196,721 (3,277) Corporate debt securities 40,458 (847) 14,604 (261) 55,062 (1,108) Total $ 599,142 $ (8,440) $ 23,489 $ (379) $ 622,631 $ (8,819) As of December 31, 2021, the securities in a continuous unrealized loss position for 12 months or longer were not material. The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): September 30, 2022 Amortized Cost Fair Value Due within one year $ 542,730 $ 538,146 Due after one year but within five years 183,804 179,581 Total $ 726,534 $ 717,727 Accrued interest receivable of $1.8 million was classified in prepaid expenses and other current assets in the condensed consolidated balance sheet of as September 30, 2022. In addition to available-for-sale debt securities, marketable securities also include term bond mutual funds, which are measured at fair value. As of September 30, 2022 and December 31, 2021, the fair value of the term bond mutual funds was $1.5 million and $3.7 million, respectively. The change in fair value of the term bond mutual funds is recorded in interest and other income, net in the condensed consolidated statements of operations. The realized and unrealized gains recognized in the condensed consolidated statements of operations for the term bond mutual funds were not material during the three and nine months ended September 30, 2022 and 2021. Prior to September 2021, the Company had non-marketable equity investments in privately held entities which have no readily determinable fair values. These investments were recorded at cost, less impairment. In September 2021, the Company sold its interest in a privately held entity for proceeds totaling $24.0 million, resulting in a gain of $23.8 million, which was recorded in interest and other income, net, in the condensed consolidated statements of operations.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable. Money market funds and U.S. treasury securities are classified within Level 1 because they are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Other debt securities and investments are classified within Level 2 if the investments are valued using model driven valuations which use observable inputs such as quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Available-for-sale debt securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. The Company did not have any assets or liabilities subject to fair value remeasurement on a nonrecurring basis as of September 30, 2022 and December 31, 2021. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 266,193 $ — $ 266,193 U.S. treasury securities 44,367 — 44,367 U.S. government agency securities — 80,238 80,238 Corporate debt securities — 4,889 4,889 Marketable securities: U.S. treasury securities 417,254 — 417,254 U.S. government agency securities — 198,223 198,223 Corporate debt securities — 102,250 102,250 Term bond mutual funds — 1,491 1,491 Total financial assets $ 727,814 $ 387,091 $ 1,114,905 December 31, 2021 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 684,485 $ — $ 684,485 U.S. treasury securities 22,000 — 22,000 U.S. government agency securities — 4,285 4,285 Corporate debt securities — 15,998 15,998 Marketable securities: U.S. treasury securities 442,285 — 442,285 U.S. government agency securities — 75,566 75,566 Corporate debt securities — 54,177 54,177 Term bond mutual funds — 3,651 3,651 Total financial assets $ 1,148,770 $ 153,677 $ 1,302,447

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, net The following table summarizes property and equipment, net as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Computers $ 15,526 $ 13,041 Capitalized internal-use software 18,552 14,178 Office equipment 3,649 3,375 Furniture and fixtures 8,769 8,395 Motor vehicles 1,171 1,421 Leasehold improvements 5,195 4,274 Construction in progress 345 — Total property and equipment 53,207 44,684 Less: accumulated depreciation and amortization (29,826) (23,206) Property and equipment, net $ 23,381 $ 21,478 Capitalization of costs associated with internal-use software were $1.2 million and $1.3 million for the three months ended September 30, 2022 and 2021, respectively; and $5.1 million and $3.5 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022 and December 31, 2021, the net carrying value of capitalized internal-use software was $10.4 million and $8.3 million, respectively. Depreciation and amortization expense was $2.6 million and $2.3 million for the three months ended September 30, 2022 and 2021, respectively; and $7.3 million and $6.6 million for the nine months ended September 30, 2022 and 2021, respectively. Accrued Liabilities The following table summarizes accrued liabilities as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Accrued compensation $ 17,540 $ 17,261 Accrued third-party cloud infrastructure expenses 2,844 2,785 Accrued reseller commissions 6,517 5,870 Accrued advertising and marketing expenses 6,877 6,022 Advanced payments from customers 3,359 3,260 Accrued taxes 5,879 10,777 Operating lease liabilities, current 5,334 — Contributions withheld for employee stock purchase plan 3,960 4,211 Other accrued expenses 5,137 5,643 Total accrued liabilities $ 57,447 $ 55,829

Intangible Assets, Net

Intangible Assets, Net	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	Intangible Assets, NetAcquired intangible assets consist of developed technology and customer relationships and are amortized on a straight-line basis over their estimated useful lives. The following tables summarize acquired intangible assets as of September 30, 2022 and December 31, 2021: September 30, 2022 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (amounts in thousands) (in years) Developed technology $ 10,496 $ (10,162) $ 334 0.5 Customer relationships 1,600 (1,355) 245 0.7 Total $ 12,096 $ (11,517) $ 579 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (amounts in thousands) (in years) Developed technology $ 10,496 $ (9,147) $ 1,349 0.9 Customer relationships 1,600 (1,055) 545 1.4 Total $ 12,096 $ (10,202) $ 1,894 Amortization of acquired intangible assets is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Developed technology: Cost of revenue $ 175 $ 990 $ 1,015 $ 2,939 Customer relationships: Sales and marketing 101 101 300 299 Total amortization expense $ 276 $ 1,091 $ 1,315 $ 3,238 As of September 30, 2022, expected future amortization expense related to acquired intangible assets is as follows (in thousands): Year Ending December 31, Amortization Expense 2022 (remaining three months) 276 2023 303 Total future amortization $ 579

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases The Company has operating leases primarily for office space. The leases have remaining lease terms of one The following table presents various components of the lease costs (in thousands): Operating Leases Three months ended September 30, 2022 Nine months ended September 30, 2022 Operating lease cost $ 2,147 $ 6,026 Short-term lease cost 250 907 Variable lease cost 660 2,098 Rent expense for operating leases recognized prior to our adoption of Topic 842 for the three and nine months ended September 30, 2021 was $2.4 million and $7.3 million, respectively. The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate September 30, 2022 Weighted-average remaining lease term (in years) 5.0 Weighted-average discount rate 7.3 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Supplemental Cash Flow Information: Three months ended September 30, 2022 Nine months ended September 30, 2022 Cash payments included in the measurement of operating lease liabilities $ 3,126 $ 7,400 Operating ROU assets obtained in exchange for lease obligations 1,749 8,968 As of September 30, 2022, maturities of the operating lease liabilities are as follows (in thousands): Year Ending December 31: Operating Leases 2022 (remaining three months) $ 809 2023 8,799 2024 7,914 2025 6,975 2026 4,672 Thereafter 8,082 Total lease payments 37,251 Less: imputed interest (7,287) Present value of operating lease liabilities $ 29,964 As of September 30, 2022, there were no future payments related to signed leases that have not yet commenced. Future minimum lease payments under non-cancelable operating leases of December 31, 2021 were as follows (in thousands): Year Ending December 31: Operating Leases 2022 $ 6,954 2023 6,790 2024 6,642 2025 5,976 2026 3,579 Thereafter 4,304 Total minimum future payments $ 34,245

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Other Contractual Commitments The Company's other contractual commitments primarily consist of third-party cloud infrastructure agreements and service subscription purchase arrangements used to support operations at the enterprise level. As of September 30, 2022, other contractual commitments totaling $113.1 million remain outstanding under these agreements though 2025. Litigation and Loss Contingencies From time to time, the Company may be subject to other legal proceedings, claims, investigations, and government inquiries (collectively, Legal Proceedings) in the ordinary course of business. It may receive claims from third parties asserting, among other things, infringement of their intellectual property rights, defamation, labor and employment rights, privacy, and contractual rights. There are no currently pending legal proceedings that the Company believes will have a material adverse impact on the business or condensed consolidated financial statements. Indemnifications In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to customers, business partners, and other parties with respect to certain matters, including losses arising out of intellectual property infringement claims made by third parties, if the Company has violated applicable laws, if the Company is negligent or commits acts of willful misconduct, and other liabilities with respect to its products and services and its business. In these circumstances, payment is typically conditional on the other party making a claim pursuant to the procedures specified in the particular contract. The Company also indemnifies certain of its officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, the Company has not incurred any material costs as a result of such indemnifications and has not accrued any liabilities related to such obligations in its condensed consolidated financial statements.

Stockholders' Equity and Stock

Stockholders' Equity and Stock Based Compensation	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Equity and Stock-Based Compensation	Stockholders' Equity and Stock-Based Compensation Equity Compensation Plans In August 2021, the board of directors (the Board) adopted the 2021 Equity Incentive Plan (the 2021 Plan) and the 2021 Employee Stock Purchase Plan (ESPP), effective upon the Company's initial public offering (IPO). Pursuant to the 2021 Plan, the Board may grant incentive stock options to purchase shares of the Company’s common stock, non-statutory stock options to purchase shares of the Company’s common stock, stock appreciation rights, restricted stock, RSUs, performance awards (PRSUs) and other awards. The ESPP enables eligible employees to purchase the Company's Class A common stock. Both the 2021 Plan and ESPP include an automatic increase to their shares reserve on January 1 of each year as set forth in the respective plan documents. In August 2022, the Board adopted the 2022 Inducement Plan (the Inducement Plan) in accordance with Listing Rule 5635(c)(4) of the Nasdaq Stock Market. Under the Inducement Plan, nonstatutory stock options, stock appreciation rights, restricted stock, RSUs, PRSUs and other awards may be granted as an inducement material for eligible persons to enter into employment with the Company. Upon adoption, the Company has initially reserved 10,000,000 shares of Class A common stock for issuance under the Inducement Plan. In September 2022, the Company hired a President, and granted him 1,732,501 RSUs under the Inducement Plan and stock options to purchase up to 1,815,980 shares of Class A common stock, of which stock options to purchase up to 1,776,780 shares of Class A common stock were granted under the Inducement Plan and the remaining under the 2021 Plan. Each award will vest over four years with 25% of the shares vesting on the first anniversary of the grant date and the remaining 75% of the shares vesting in equal quarterly installments thereafter, subject to continued employment. Shares of common stock reserved for future issuance were as follows (in thousands): September 30, 2022 2011 Stock Plan: Options and RSUs outstanding 25,057 2021 Equity Incentive Plan: Options, RSUs and PRSUs outstanding 9,986 Shares reserved for future award issuances 50,477 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 8,698 Total shares of common stock reserved for issuance 104,218 2021 Employee Stock Purchase Plan Under the ESPP, the price at which common stock is purchased is equal to 85% of the fair market value of a share of the Company’s common stock on the first day of the offering period or the applicable purchase date, whichever is lower. The fair market value of common stock will generally be the closing sales price on the determination date. The ESPP provides an offering period of 24 months, with four purchase periods that are generally six months long and end on May 15 and November 15 of each year, except for the first purchase period, which began upon the completion of the IPO in September 2021 and ended on May 13, 2022. The Company issued 510,093 shares under the ESPP in the nine months ended September 30, 2022, net of shares withheld and retired to satisfy withholding tax requirements for certain employees in jurisdictions outside the US, with a weighted average purchase price of $13.76 and aggregate net proceeds of $7.0 million. The ESPP also includes a reset provision for the purchase price if the fair market value of a share of the Company's common stock on the first day of any purchase period is less than or equal to the fair market value of a share of the Company's common stock on the first day of an ongoing offering. The reset provision under the ESPP was triggered on May 16, 2022, resulting in a new 24-month offering period that began on May 16, 2022. The reset is considered a modification in accordance with ASC 718, Stock Based Compensation , with the modification charge recognized on a straight-line basis over the new offering period. The modification did not have a material effect on the Company's stock-based compensation expense during the nine months ended September 30, 2022. During the three and nine months ended September 30, 2022, the Company recognized $2.2 million and $9.4 million of stock-based compensation expense related to the ESPP, respectively. Determination of Fair Value of the ESPP The Company estimates the fair value of the ESPP using the Black-Scholes option-pricing model, which requires certain complex valuation assumption inputs such as expected term, expected stock price volatility, risk-free interest rate, and dividend yield. The fair value of each of the four purchase periods is estimated separately. The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2022 Expected term (in years) 0.5 - 2.0 Stock price volatility 55.8% - 84.5% Risk-free interest rate 1.54% - 2.58% Dividend yield —% Expected term —The expected term is estimated based on the exercise term of the ESPP, which is the length of time from the grant date to the date on which the stock is purchased by the employees. Stock price volatility —Since the Company's common stock lacks sufficient trading history, the stock price volatility over the expected term ranging from one Risk-free interest rate —The risk-free interest rate is based on the yield of the U.S. Treasury debt securities commensurate with the expected term of the ESPP. Dividend yield —Since the Company has never paid and has no intention to pay cash dividends on its common stock, the dividend yield is zero. Fair value of underlying stock —The fair value of the Company's common stock underlying the ESPP is determined by the closing market price of its Class A common stock on the grant date, which was May 16, 2022. Stock Options Stock options are generally granted with an exercise price equal to the stock’s fair market value at the date of grant, have 10-year contractual terms, and vest over a four-year period. Share Information: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (1) Balance as of December 31, 2021 1,348 $ 0.27 3.6 $ 35,020 Stock options granted 1,816 $ 13.61 Stock options exercised (383) $ 0.27 Stock options cancelled / forfeited / expired — $ — Balance as of September 30, 2022 2,781 $ 8.98 7.5 $ 12,260 Options vested and expected to vest as of September 30, 2022 2,781 $ 8.98 7.5 $ 12,260 Options exercisable as of September 30, 2022 965 $ 0.27 2.9 $ 12,260 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested. The weighted-average grant date fair value of stock options granted was $8.26 per share during the three and nine months ended September 30, 2022. Determination of Fair Value of Stock Options The Company estimates the fair value of stock options using the Black-Scholes option-pricing model, which requires certain complex valuation assumption inputs such as expected term, expected stock price volatility, risk-free interest rate, and dividend yield. The following table summarizes the range of valuation assumptions used in estimating the fair value of stock options during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2022 Expected term (in years) 6.1 Stock price volatility 65.0% Risk-free interest rate 3.37% Dividend yield —% Expected term —The expected term represents the period of time the stock options are expected to be outstanding, calculated using the simplified method which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company considers this appropriate as there is not sufficient historical information available to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior. Stock price volatility —Since the Company's common stock lacks sufficient trading history, the stock price volatility over the expected term is estimated based on the average historical volatility of comparable companies with similar characteristics to those of the Company. Risk-free interest rate —The risk-free interest rate is based on the yield of the U.S. Treasury debt securities commensurate with the expected term. Dividend yield —Since the Company has never paid and has no intention to pay cash dividends on its common stock, the dividend yield is zero. Fair value of underlying stock —The fair value of Company's common stock is determined by the closing market price of its Class A common stock on the grant date. Restricted Stock Units RSUs are granted at fair market value at the date of the grant and vest over a four-year period. RSU activity, which includes PRSUs, during the nine months ended September 30, 2022 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2021 47,830 $ 14.47 Granted 12,048 $ 17.19 Vested (21,568) $ 8.88 Forfeited (2,539) $ 16.54 Unvested, as of September 30, 2022 35,771 $ 18.60 During the three and nine months ended September 30, 2022, total shares that vested were 2.6 million and 21.6 million, of which 1.0 million shares and 8.6 million shares were withheld for tax withholding requirements, respectively. On February 14, 2022, the final lock-up period following the IPO expired, and the Company issued an aggregate of 9.3 million shares of its common stock, net of shares withheld for taxes, as settlement of all RSUs that had met the time-based service condition. Total cash paid related to the withholding taxes on net share settlement of equity awards amounted to $13.4 million and $151.7 million during the three and nine months ended September 30, 2022, respectively. Performance-Based Awards In May 2019, the Board approved a grant of 166,390 shares of PRSUs to the Company’s CEO. The vesting of these PRSUs is contingent upon the satisfaction of certain milestones. The revenue-related milestone and the liquidity event condition were met prior to December 31, 2021. As of September 30, 2022, the time-based vesting was the only condition yet to be satisfied over the remaining requisite service period, and the number of shares to vest subject to this condition is insignificant. In September 2021, the Board approved a grant of 6,000,000 PRSUs to the Company's CEO with a time-based service condition beginning January 1, 2022, and a market condition involving five separate stock price targets ranging from $70.00 to $200.00 per share for each of the five vesting tranches (CEO Performance Award). These stock price targets will be measured based on the average closing price over a consecutive 60-trading day period, beginning on the first trading day after the expiration of the final lock-up period in February 2022. The vesting of the CEO Performance Award is contingent upon the completion of the requisite service through January 1, 2029 and the achievement of the specified stock price target in each tranche on or before January 1, 2029. The stock price targets are not required to be achieved within the service period of each tranche, and accordingly, multiple tranches can vest at the same date if the specified stock price targets are achieved after December 31, 2025. The CEO Performance Award had a total grant date fair value of $131.0 million. The fair value of the CEO Performance Award was determined at grant date by using the Monte Carlo simulation model, which requires certain complex valuation assumption inputs such as measurement period, expected stock price volatility, risk-free interest rate and dividend yield. The Company recognized stock-based compensation expense associated with PRSUs granted to the CEO of $7.1 million and $1.4 million for the three months ended September 30, 2022 and 2021, respectively; and $21.0 million and $1.4 million for the nine months ended September 30, 2022 and 2021, respectively. These expenses were recorded in general and administrative expenses in the condensed consolidated statements of operations. Stock-Based Compensation Total stock-based compensation expense recorded for the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of revenue $ 1,772 $ 3,983 $ 5,212 $ 3,983 Research and development 10,318 36,823 26,446 36,823 Sales and marketing 16,635 40,465 44,204 40,465 General and administrative (1) 25,167 42,988 74,790 42,988 Stock-based compensation, net of amounts capitalized 53,892 124,259 150,652 124,259 Capitalized stock-based compensation 52 458 1,275 458 Total stock-based compensation expense $ 53,944 $ 124,717 $ 151,927 $ 124,717 (1) General and administrative expense includes $14.1 million and $10.4 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the three months ended September 30, 2022 and 2021, respectively; and $41.8 million and $10.4 million for the nine months ended September 30, 2022 and 2021, respectively. As of September 30, 2022, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): September 30, 2022 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 596,666 3.1 Stock options 14,702 3.9 ESPP 11,862 1.0 Total unrecognized stock-based compensation expense $ 623,230

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per ShareBasic net loss per share attributable to common stockholders is computed by dividing the net loss by the number of weighted-average outstanding common shares. Diluted net loss per share attributable to common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The Company considers its redeemable convertible preferred stock, stock options and restricted stock units as potential common stock equivalents, but excluded them from the computation of diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2022 and 2021, as their effect was antidilutive. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders, are the same for both Class A and Class B common stock on both an individual and combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss $ (57,843) $ (107,415) $ (176,655) $ (117,259) Accretion of redeemable convertible preferred stock — (2,264,838) — (2,646,662) Net loss attributable to Class A and Class B common stockholders - basic and diluted $ (57,843) $ (2,372,253) $ (176,655) $ (2,763,921) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 286,697 95,930 283,258 83,860 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.20) $ (24.72) $ (0.62) $ (32.96) The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three and Nine Months Ended September 30, 2022 2021 RSUs and PRSUs 35,771 58,636 Stock options 2,781 1,682 ESPP 359 — Total 38,911 60,318

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company's quarterly tax provision and estimates of its annual effective tax rate are estimates due to several factors, including changes in pre-tax income (or loss), the mix of jurisdictions to which such income relates, discrete items (such as excess tax benefits from stock-based compensation) in the period offset with our valuation allowance. The provision for (benefit from) income taxes was $1.8 million and $(9.9) million for the three months ended September 30, 2022 and 2021, respectively; and $6.5 million and $(7.7) million for the nine months ended September 30, 2022 and 2021, respectively. The increase in the provision for income taxes in the three and nine months ended September 30, 2022 resulted primarily from a tax benefit of $11.7 million mostly from stock-based compensation expense recorded during the three and nine months ended September 30, 2021, in jurisdictions where we expect to realize a tax benefit. Additionally, the increase in the provision for income taxes is also attributable to higher tax expense from profitable foreign jurisdictions.

Geographic Information

Geographic Information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Geographic Information	Geographic Information The following table summarizes revenue by geographic location (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 North America $ 56,288 $ 41,961 $ 157,178 $ 113,668 Europe, Middle East and Africa 49,786 39,566 143,169 110,695 Asia Pacific 19,296 12,955 55,015 35,382 Other 3,390 2,132 9,467 5,797 Total revenue $ 128,760 $ 96,614 $ 364,829 $ 265,542 The following table summarizes long-lived assets by geographic information (in thousands): September 30, 2022 December 31, 2021 North America $ 21,364 $ 13,780 Europe, Middle East and Africa 4,358 578 Asia Pacific 26,480 9,015 Total long-lived assets $ 52,202 $ 23,373

Business, Basis of Presentati_2

Business, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, and all intercompany balances and transactions have been eliminated in consolidation. Unaudited Interim Consolidated Financial Statement s The accompanying condensed consolidated balance sheet as of September 30, 2022, the condensed consolidated statements of operations, of comprehensive loss, of cash flows, and of redeemable convertible preferred stock and stockholders’ equity (deficit) for the three and nine months ended September 30, 2022 and 2021, and the related notes to such condensed consolidated financial statements are unaudited. These unaudited condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of September 30, 2022 and its results of operations and cash flows for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the following: • determination of standalone selling price (SSP) for each distinct performance obligation included in customer contracts with multiple performance obligations; • allowance for doubtful accounts; • expected benefit period of deferred contract acquisition costs; • capitalization of internal-use software development costs; • fair value of acquired intangible assets and goodwill; • useful lives of long-lived assets; • valuation of deferred tax assets; • valuation of employee defined benefit plan; • fair value of share-based awards, including performance-based awards; and • incremental borrowing rate used for operating leases.
Concentrations of Risk	Concentrations of Risk Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company’s cash and cash equivalents and marketable securities are generally held with large financial institutions and are in excess of the federally insured limits provided on such deposits. In addition, the Company has cash and cash equivalents held in international bank accounts, which are denominated primarily in Euros, British Pounds, and Indian Rupees. There were no customers that individually exceeded 10% of the Company’s revenue for the three and nine months ended September 30, 2022 and 2021 or that represented 10% or more of the Company’s consolidated accounts receivable balance as of September 30, 2022.
Leases	Leases The Company leases office space under operating leases with expiration dates through 2031. The Company determines whether an arrangement constitutes a lease and records lease liabilities and right-of-use (ROU) assets on its condensed consolidated balance sheets at the lease commencement date. Lease liabilities are measured based on the present value of the total lease payments not yet paid, discounted based on either the rate implicit in the lease or the Company's incremental borrowing rate (the estimated rate the Company would be required to pay for a collateralized borrowing equal to the total lease payments over the term of the lease), whichever is more readily determinable. Lease liabilities due within 12 months are included within accrued liabilities on the Company's condensed consolidated balance sheets. The incremental borrowing rate is based on an estimate of the Company's expected unsecured borrowing rate for its notes, adjusted for tenor and collateralized security features. ROU assets are measured based on the corresponding lease liability adjusted for (i) payments made to the lessor at or before the lease commencement date, (ii) initial direct costs incurred, and (iii) tenant incentives received, incurred or payable under the lease. Recognition of rent expense begins when the lessor makes the underlying asset available to the Company. The Company does not assume renewals or early terminations of its leases unless it is reasonably certain to exercise these options at commencement and does not allocate consideration between lease and non-lease components. For short-term leases, the Company records rent expense in its condensed consolidated statements of operations on a straight-line basis over the lease term and records variable lease payments as incurred.
Recent Accounting Pronouncements	Recent Accounting Pronouncements New accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) under its Accounting Standards Codification (ASC) or ASU and adopted by the Company as of the specified effective date. Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires lessees to recognize most leases on their balance sheets as ROU assets with corresponding lease liabilities and eliminates certain real estate-specific provisions. The Company adopted this standard effective January 1, 2022 on a modified retrospective basis, and as such, results in comparative periods were not restated. As a result of the adoption, the Company recognized operating ROU assets of $24.3 million and operating lease liabilities of $28.8 million in its condensed consolidated balance sheets on the adoption date. The Company has elected certain available practical expedients, which allow it to forego the reassessments of (i) whether any expired or existing contracts are or contain leases, (ii) the lease classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. The Company has also elected to combine lease and non-lease components for commercial lease arrangements. Additionally, the Company elected not to recognize operating ROU assets and the associated operating lease liabilities for leases with a term of 12 months or less from the lease commencement date. In June 2016, the FASB issued ASU 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets by requiring an allowance to be recorded as an offset to the amortized cost of such assets. The standard primarily impacts the amortized cost of the Company's available-for-sale debt securities. The Company adopted this standard on January 1, 2022 using the modified retrospective approach, which did not result in a material impact on its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740). The standard eliminates certain exceptions related to the approach for intraperiod tax allocation and the methodology for calculating income taxes in an interim period. The standard also simplifies aspects of accounting for franchise taxes and enacted changes in tax or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis for goodwill. The Company adopted this standard effective January 1, 2022, which did not result in a material impact on its condensed consolidated financial statements.
Revenue	Revenue The Company derives revenue from subscription fees and related professional services. The Company sells subscriptions for its cloud-based solutions directly to customers and indirectly through channel partners through arrangements that are non-cancelable and non-refundable. The Company’s subscription arrangements do not provide customers with the right to take possession of the software supporting the solutions and, as a result, are accounted for as service arrangements. The Company records revenue net of sales or value-added taxes.
Fair Value Measurements	The Company measures its financial assets at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Inputs are observable and reflect quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 —Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly. Level 3 —Inputs that are unobservable.

Revenue From Contracts with C_2

Revenue From Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenues	The following table summarizes revenue by the Company’s service offerings (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Subscription services $ 125,508 $ 94,312 $ 355,298 $ 257,827 Professional services 3,252 2,302 9,531 7,715 Total revenue $ 128,760 $ 96,614 $ 364,829 $ 265,542
Summary of Changes in the Balance of Deferred Contract Acquisition Costs	The change in the balance of deferred contract acquisition costs during the periods presented is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Balance at beginning of the period $ 33,592 $ 23,604 $ 29,647 $ 18,273 Add: Contract costs capitalized during the period 6,913 6,032 19,554 17,032 Less: Amortization of contract costs during the period (4,625) (3,416) (13,321) (9,085) Balance at end of the period $ 35,880 $ 26,220 $ 35,880 $ 26,220

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-sale Securities Reconciliation	Cash equivalents and available-for-sale debt securities consisted of the following as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 266,193 $ — $ — $ 266,193 U.S. treasury securities 44,363 4 — 44,367 U.S. government agency securities 80,225 14 (1) 80,238 Corporate debt securities 4,889 — — 4,889 Total cash equivalents 395,670 18 (1) 395,687 Debt securities: U.S. treasury securities 421,677 11 (4,434) 417,254 U.S. government agency securities 201,499 1 (3,277) 198,223 Corporate debt securities 103,358 — (1,108) 102,250 Total debt securities 726,534 12 (8,819) 717,727 Total cash equivalents and debt securities $ 1,122,204 $ 30 $ (8,820) $ 1,113,414 December 31, 2021 Amortized Cost Unrealized Gains Unrealized Losses Fair Value Cash equivalents: Money market funds $ 684,485 $ — $ — $ 684,485 U.S. treasury securities 22,000 — — 22,000 U.S. government agency securities 4,286 — (1) 4,285 Corporate debt securities 15,998 — — 15,998 Total cash equivalents 726,769 — (1) 726,768 Debt securities: U.S. treasury securities 442,715 2 (432) 442,285 U.S. government agency securities 75,725 — (159) 75,566 Corporate debt securities 54,335 17 (175) 54,177 Total debt securities 572,775 19 (766) 572,028 Total cash equivalents and debt securities $ 1,299,544 $ 19 $ (767) $ 1,298,796
Schedule of Available-for-Sale, Unrealized Loss Position, Fair Value	The following table presents gross unrealized losses and fair values for the securities that were in a continuous unrealized loss position as of September 30, 2022 (in thousands): September 30, 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 361,963 $ (4,316) $ 8,885 $ (118) $ 370,848 $ (4,434) U.S. government agency securities 196,721 (3,277) — — 196,721 (3,277) Corporate debt securities 40,458 (847) 14,604 (261) 55,062 (1,108) Total $ 599,142 $ (8,440) $ 23,489 $ (379) $ 622,631 $ (8,819)
Schedule of Amortized Costs and Fair Value of Debt Securities Based on Contractual Maturities	The amortized cost and fair value of the available-for-sale debt securities based on contractual maturities are as follows (in thousands): September 30, 2022 Amortized Cost Fair Value Due within one year $ 542,730 $ 538,146 Due after one year but within five years 183,804 179,581 Total $ 726,534 $ 717,727

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table represents the fair value hierarchy for the Company’s financial assets measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 266,193 $ — $ 266,193 U.S. treasury securities 44,367 — 44,367 U.S. government agency securities — 80,238 80,238 Corporate debt securities — 4,889 4,889 Marketable securities: U.S. treasury securities 417,254 — 417,254 U.S. government agency securities — 198,223 198,223 Corporate debt securities — 102,250 102,250 Term bond mutual funds — 1,491 1,491 Total financial assets $ 727,814 $ 387,091 $ 1,114,905 December 31, 2021 Fair Value Measured Using Level 1 Level 2 Total Financial assets: Cash equivalents: Money market funds $ 684,485 $ — $ 684,485 U.S. treasury securities 22,000 — 22,000 U.S. government agency securities — 4,285 4,285 Corporate debt securities — 15,998 15,998 Marketable securities: U.S. treasury securities 442,285 — 442,285 U.S. government agency securities — 75,566 75,566 Corporate debt securities — 54,177 54,177 Term bond mutual funds — 3,651 3,651 Total financial assets $ 1,148,770 $ 153,677 $ 1,302,447

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property, Plant and Equipment	The following table summarizes property and equipment, net as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Computers $ 15,526 $ 13,041 Capitalized internal-use software 18,552 14,178 Office equipment 3,649 3,375 Furniture and fixtures 8,769 8,395 Motor vehicles 1,171 1,421 Leasehold improvements 5,195 4,274 Construction in progress 345 — Total property and equipment 53,207 44,684 Less: accumulated depreciation and amortization (29,826) (23,206) Property and equipment, net $ 23,381 $ 21,478
Schedule of Accrued Liabilities	Accrued Liabilities The following table summarizes accrued liabilities as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 December 31, 2021 Accrued compensation $ 17,540 $ 17,261 Accrued third-party cloud infrastructure expenses 2,844 2,785 Accrued reseller commissions 6,517 5,870 Accrued advertising and marketing expenses 6,877 6,022 Advanced payments from customers 3,359 3,260 Accrued taxes 5,879 10,777 Operating lease liabilities, current 5,334 — Contributions withheld for employee stock purchase plan 3,960 4,211 Other accrued expenses 5,137 5,643 Total accrued liabilities $ 57,447 $ 55,829

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Acquired intangible assets consist of developed technology and customer relationships and are amortized on a straight-line basis over their estimated useful lives. The following tables summarize acquired intangible assets as of September 30, 2022 and December 31, 2021: September 30, 2022 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (amounts in thousands) (in years) Developed technology $ 10,496 $ (10,162) $ 334 0.5 Customer relationships 1,600 (1,355) 245 0.7 Total $ 12,096 $ (11,517) $ 579 December 31, 2021 Gross Amount Accumulated Amortization Net Carrying Value Weighted Average Remaining Useful Life (amounts in thousands) (in years) Developed technology $ 10,496 $ (9,147) $ 1,349 0.9 Customer relationships 1,600 (1,055) 545 1.4 Total $ 12,096 $ (10,202) $ 1,894
Finite-lived Intangible Assets Amortization Expense	Amortization of acquired intangible assets is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Developed technology: Cost of revenue $ 175 $ 990 $ 1,015 $ 2,939 Customer relationships: Sales and marketing 101 101 300 299 Total amortization expense $ 276 $ 1,091 $ 1,315 $ 3,238
Summary of Estimated Future Amortization Expense	As of September 30, 2022, expected future amortization expense related to acquired intangible assets is as follows (in thousands): Year Ending December 31, Amortization Expense 2022 (remaining three months) 276 2023 303 Total future amortization $ 579

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Lease, Cost	The following table presents various components of the lease costs (in thousands): Operating Leases Three months ended September 30, 2022 Nine months ended September 30, 2022 Operating lease cost $ 2,147 $ 6,026 Short-term lease cost 250 907 Variable lease cost 660 2,098 The weighted-average remaining term of the Company's operating leases and the weighted-average discount rate used to measure the present value of the operating lease liabilities are as follows: Lease Term and Discount Rate September 30, 2022 Weighted-average remaining lease term (in years) 5.0 Weighted-average discount rate 7.3 % The following table presents supplemental information arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of the operating lease liabilities, and as such, are excluded from the amounts below (in thousands): Supplemental Cash Flow Information: Three months ended September 30, 2022 Nine months ended September 30, 2022 Cash payments included in the measurement of operating lease liabilities $ 3,126 $ 7,400 Operating ROU assets obtained in exchange for lease obligations 1,749 8,968
Lessee, Operating Lease, Liability, Maturity	As of September 30, 2022, maturities of the operating lease liabilities are as follows (in thousands): Year Ending December 31: Operating Leases 2022 (remaining three months) $ 809 2023 8,799 2024 7,914 2025 6,975 2026 4,672 Thereafter 8,082 Total lease payments 37,251 Less: imputed interest (7,287) Present value of operating lease liabilities $ 29,964
Schedule of Future Minimum Rental Payments for Operating Leases	Future minimum lease payments under non-cancelable operating leases of December 31, 2021 were as follows (in thousands): Year Ending December 31: Operating Leases 2022 $ 6,954 2023 6,790 2024 6,642 2025 5,976 2026 3,579 Thereafter 4,304 Total minimum future payments $ 34,245

Stockholders' Equity and Stoc_2

Stockholders' Equity and Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Summary of Common Shares Reserved for Future Issuance	Shares of common stock reserved for future issuance were as follows (in thousands): September 30, 2022 2011 Stock Plan: Options and RSUs outstanding 25,057 2021 Equity Incentive Plan: Options, RSUs and PRSUs outstanding 9,986 Shares reserved for future award issuances 50,477 2022 Inducement Plan: Options and RSUs outstanding 3,509 Shares reserved for future award issuances 6,491 2021 Employee Stock Purchase Plan 8,698 Total shares of common stock reserved for issuance 104,218
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The following table summarizes the range of valuation assumptions used in estimating the fair value of the ESPP during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2022 Expected term (in years) 0.5 - 2.0 Stock price volatility 55.8% - 84.5% Risk-free interest rate 1.54% - 2.58% Dividend yield —%
Schedule of Stock Option Activity	Share Information: Number of Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (1) Balance as of December 31, 2021 1,348 $ 0.27 3.6 $ 35,020 Stock options granted 1,816 $ 13.61 Stock options exercised (383) $ 0.27 Stock options cancelled / forfeited / expired — $ — Balance as of September 30, 2022 2,781 $ 8.98 7.5 $ 12,260 Options vested and expected to vest as of September 30, 2022 2,781 $ 8.98 7.5 $ 12,260 Options exercisable as of September 30, 2022 965 $ 0.27 2.9 $ 12,260 (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s common stock as of the end of the period, multiplied by the number of stock options outstanding, exercisable, or vested.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table summarizes the range of valuation assumptions used in estimating the fair value of stock options during the period: Valuation Assumption Inputs Nine Months Ended September 30, 2022 Expected term (in years) 6.1 Stock price volatility 65.0% Risk-free interest rate 3.37% Dividend yield —%
Schedule of Restricted Stock Unit Activity	RSU activity, which includes PRSUs, during the nine months ended September 30, 2022 is as follows: Share Information: Number of Shares Weighted-Average Grant Date Fair Value Per Share (in thousands, except per share data) Unvested, as of December 31, 2021 47,830 $ 14.47 Granted 12,048 $ 17.19 Vested (21,568) $ 8.88 Forfeited (2,539) $ 16.54 Unvested, as of September 30, 2022 35,771 $ 18.60
Stock-based Compensation Expense	Total stock-based compensation expense recorded for the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Cost of revenue $ 1,772 $ 3,983 $ 5,212 $ 3,983 Research and development 10,318 36,823 26,446 36,823 Sales and marketing 16,635 40,465 44,204 40,465 General and administrative (1) 25,167 42,988 74,790 42,988 Stock-based compensation, net of amounts capitalized 53,892 124,259 150,652 124,259 Capitalized stock-based compensation 52 458 1,275 458 Total stock-based compensation expense $ 53,944 $ 124,717 $ 151,927 $ 124,717 (1) General and administrative expense includes $14.1 million and $10.4 million of stock-based compensation expense associated with RSUs and PRSUs primarily granted to the CEO in September 2021 for the three months ended September 30, 2022 and 2021, respectively; and $41.8 million and $10.4 million for the nine months ended September 30, 2022 and 2021, respectively.
Share-based Payment Arrangement, Nonvested Award, Cost	As of September 30, 2022, unrecognized stock-based compensation expense related to unvested stock-based awards was as follows (in thousands, except for period data): September 30, 2022 Unrecognized Stock-Based Compensation Weighted-Average Period to Recognize Expense RSUs and PRSUs $ 596,666 3.1 Stock options 14,702 3.9 ESPP 11,862 1.0 Total unrecognized stock-based compensation expense $ 623,230

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Numerator: Net loss $ (57,843) $ (107,415) $ (176,655) $ (117,259) Accretion of redeemable convertible preferred stock — (2,264,838) — (2,646,662) Net loss attributable to Class A and Class B common stockholders - basic and diluted $ (57,843) $ (2,372,253) $ (176,655) $ (2,763,921) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted 286,697 95,930 283,258 83,860 Net loss per share attributable to Class A and Class B common stockholders - basic and diluted $ (0.20) $ (24.72) $ (0.62) $ (32.96)
Schedule of Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share	The following table summarizes the potential common equivalents that were excluded from the computation of diluted net loss per share attributable to Class A and Class B common stockholders for the periods presented (in thousands): Three and Nine Months Ended September 30, 2022 2021 RSUs and PRSUs 35,771 58,636 Stock options 2,781 1,682 ESPP 359 — Total 38,911 60,318

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Schedule of Revenue and Long-Lived Assets by Geographical Region	The following table summarizes revenue by geographic location (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 North America $ 56,288 $ 41,961 $ 157,178 $ 113,668 Europe, Middle East and Africa 49,786 39,566 143,169 110,695 Asia Pacific 19,296 12,955 55,015 35,382 Other 3,390 2,132 9,467 5,797 Total revenue $ 128,760 $ 96,614 $ 364,829 $ 265,542 The following table summarizes long-lived assets by geographic information (in thousands): September 30, 2022 December 31, 2021 North America $ 21,364 $ 13,780 Europe, Middle East and Africa 4,358 578 Asia Pacific 26,480 9,015 Total long-lived assets $ 52,202 $ 23,373

Business, Basis of Presentati_3

Business, Basis of Presentation and Summary of Significant Accounting Policies (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2021 $ / shares shares	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Jan. 01, 2022 USD ($)
Sale of Stock [Line Items]
Proceeds from initial public offering, net of underwriting discounts	$ 1,100,000		$ 0	$ 1,069,348
Number of shares issued in conversion (in shares)	1	1		1
Stock split ratio, common stock	10
Operating lease right-of-use assets			28,821
Present value of operating lease liabilities			$ 29,964
Common Stock
Sale of Stock [Line Items]
Conversion of redeemable convertible preferred stock into common stock upon initial public offering (in shares) | shares		153,937,730		153,938,000
Accounting Standards Update 2016-02
Sale of Stock [Line Items]
Operating lease right-of-use assets					$ 24,300
Present value of operating lease liabilities					$ 28,800
IPO
Sale of Stock [Line Items]
Public offering price (in USD per share) | $ / shares	$ 36	$ 36		$ 36
IPO | Class A Common Stock
Sale of Stock [Line Items]
Number of shares issued and sold (in shares) | shares	31,350,000

Revenue From Contracts with C_3

Revenue From Contracts with Customers - Disaggregation of Revenues (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 128,760	$ 96,614	$ 364,829	$ 265,542
Subscription services
Disaggregation of Revenue [Line Items]
Revenue	125,508	94,312	355,298	257,827
Professional services
Disaggregation of Revenue [Line Items]
Revenue	$ 3,252	$ 2,302	$ 9,531	$ 7,715

Revenue From Contracts with C_4

Revenue From Contracts with Customers - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized during the period	$ 86.2	$ 61.6	$ 146.9	$ 95.6
Remaining performance obligation	277.4		277.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 218.7		$ 218.7
Remaining performance obligation, expected timing of satisfaction, period	12 months		12 months

Revenue From Contracts with C_5

Revenue From Contracts with Customers - Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Change in Deferred Contract Acquisition Costs [Roll Forward]
Balance at beginning of the period	$ 33,592	$ 23,604	$ 29,647	$ 18,273
Add: Contract costs capitalized during the period	6,913	6,032	19,554	17,032
Less: Amortization of contract costs during the period	(4,625)	(3,416)	(13,321)	(9,085)
Balance at end of the period	$ 35,880	$ 26,220	$ 35,880	$ 26,220

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Carrying Amounts and Fair Values of Debt Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	$ 30	$ 19
Unrealized Losses	(8,820)	(767)
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	1,122,204	1,299,544
Fair Value	1,113,414	1,298,796
Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Unrealized Gains	18	0
Unrealized Losses	(1)	(1)
Cash Equivalents and Available-for-sale Debt Securities
Amortized Cost	395,670	726,769
Fair Value	395,687	726,768
Cash Equivalents | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	44,363	22,000
Unrealized Gains	4	0
Unrealized Losses	0	0
Fair Value	44,367	22,000
Cash Equivalents | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	80,225	4,286
Unrealized Gains	14	0
Unrealized Losses	(1)	(1)
Fair Value	80,238	4,285
Cash Equivalents | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	4,889	15,998
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	4,889	15,998
Marketable Securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	726,534	572,775
Unrealized Gains	12	19
Unrealized Losses	(8,819)	(766)
Fair Value	717,727	572,028
Marketable Securities | U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	421,677	442,715
Unrealized Gains	11	2
Unrealized Losses	(4,434)	(432)
Fair Value	417,254	442,285
Marketable Securities | U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	201,499	75,725
Unrealized Gains	1	0
Unrealized Losses	(3,277)	(159)
Fair Value	198,223	75,566
Marketable Securities | Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Debt securities, Amortized Cost	103,358	54,335
Unrealized Gains	0	17
Unrealized Losses	(1,108)	(175)
Fair Value	102,250	54,177
Money market funds
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents	$ 266,193	$ 684,485

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Continuous Unrealized Loss Position and Fair Values of Debt Securities (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Fair Value
Less than 12 months	$ 599,142
Greater than 12 months	23,489
Total	622,631
Unrealized Loss
Less than 12 months	(8,440)
Greater than 12 months	(379)
Total	(8,819)
U.S. treasury securities
Fair Value
Less than 12 months	361,963
Greater than 12 months	8,885
Total	370,848
Unrealized Loss
Less than 12 months	(4,316)
Greater than 12 months	(118)
Total	(4,434)
U.S. government agency securities
Fair Value
Less than 12 months	196,721
Greater than 12 months	0
Total	196,721
Unrealized Loss
Less than 12 months	(3,277)
Greater than 12 months	0
Total	(3,277)
Corporate debt securities
Fair Value
Less than 12 months	40,458
Greater than 12 months	14,604
Total	55,062
Unrealized Loss
Less than 12 months	(847)
Greater than 12 months	(261)
Total	$ (1,108)

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Amortized Cost and Fair Value Based on Contractual Maturities (Details) - Marketable Securities - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Amortized Cost
Due within one year	$ 542,730
Due after one year but within five years	183,804
Debt securities, Amortized Cost	726,534	$ 572,775
Fair Value
Due within one year	538,146
Due after one year but within five years	179,581
Total	$ 717,727	$ 572,028

Cash Equivalents and Marketab_6

Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Accrued interest		$ 1,800
Sale of non-marketable equity investment	$ 24,000	0	$ 23,979
Gain realized on sale of marketable securities and non-marketable equity investment	$ 23,800	0	$ 23,835
Mutual funds
Debt Securities, Available-for-sale [Line Items]
Equity securities		$ 1,500		$ 3,700

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	$ 1,114,905	$ 1,302,447
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	417,254	442,285
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	198,223	75,566
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	102,250	54,177
Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,491	3,651
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	266,193	684,485
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	44,367	22,000
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	80,238	4,285
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	4,889	15,998
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	727,814	1,148,770
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	417,254	442,285
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	266,193	684,485
Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	44,367	22,000
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets	387,091	153,677
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	198,223	75,566
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	102,250	54,177
Level 2 | Term bond mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	1,491	3,651
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	80,238	4,285
Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	$ 4,889	$ 15,998

Balance Sheet Components - Prop

Balance Sheet Components - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 53,207	$ 44,684
Less: accumulated depreciation and amortization	(29,826)	(23,206)
Property and equipment, net	23,381	21,478
Computers
Property, Plant and Equipment [Line Items]
Total property and equipment	15,526	13,041
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment	18,552	14,178
Office equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	3,649	3,375
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	8,769	8,395
Motor vehicles
Property, Plant and Equipment [Line Items]
Total property and equipment	1,171	1,421
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	5,195	4,274
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 345	$ 0

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized costs	$ 1.2	$ 1.3	$ 5.1	$ 3.5
Net carrying value	10.4		10.4		$ 8.3
Depreciation expense and amortization	$ 2.6	$ 2.3	$ 7.3	$ 6.6

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation	$ 17,540	$ 17,261
Accrued third-party cloud infrastructure expenses	2,844	2,785
Accrued reseller commissions	6,517	5,870
Accrued advertising and marketing expenses	6,877	6,022
Advanced payments from customers	3,359	3,260
Accrued taxes	5,879	10,777
Operating lease liabilities, current	5,334	0
Contributions withheld for employee stock purchase plan	3,960	4,211
Other accrued expenses	5,137	5,643
Accrued liabilities	$ 57,447	$ 55,829

Intangible Assets, Net - Narrat

Intangible Assets, Net - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 6,181	$ 6,181

Intangible Assets, Net - Summar

Intangible Assets, Net - Summary of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 12,096	$ 12,096
Accumulated Amortization	(11,517)	(10,202)
Net Carrying Value	579	1,894
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Amount	10,496	10,496
Accumulated Amortization	(10,162)	(9,147)
Net Carrying Value	$ 334	$ 1,349
Weighted Average Remaining Useful Life	6 months	10 months 24 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 1,600	$ 1,600
Accumulated Amortization	(1,355)	(1,055)
Net Carrying Value	$ 245	$ 545
Weighted Average Remaining Useful Life	8 months 12 days	1 year 4 months 24 days

Intangible Assets, Net - Summ_2

Intangible Assets, Net - Summary of Acquired Intangible Assets Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization of acquired intangible assets	$ 276	$ 1,091	$ 1,315	$ 3,238
Developed technology | Cost of revenue
Finite-Lived Intangible Assets [Line Items]
Amortization of acquired intangible assets	175	990	1,015	2,939
Customer relationships | Sales and marketing
Finite-Lived Intangible Assets [Line Items]
Amortization of acquired intangible assets	$ 101	$ 101	$ 300	$ 299

Intangible Assets, Net - Summ_3

Intangible Assets, Net - Summary of Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (remaining three months)	$ 276
2023	303
Net Carrying Value	$ 579	$ 1,894

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Lessee, Lease, Description [Line Items]
Operating lease, option to extend, term			6 years
Rent expense	$ 2.4	$ 7.3
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term			1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term			9 years

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 2,147	$ 6,026
Short-term lease cost	250	907
Variable lease cost	$ 660	$ 2,098

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Sep. 30, 2022
Leases [Abstract]
Weighted-average remaining lease term (in years)	5 years
Weighted average discount rate (as a percent)	7.30%

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Cash payments included in the measurement of operating lease liabilities	$ 3,126	$ 7,400
Operating lease right-of-use assets obtained in exchange for operating lease obligations	$ 1,749	$ 8,968	$ 0

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Operating Lease Liabilities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
2022 (remaining three months)	$ 809
2023	8,799
2024	7,914
2025	6,975
2026	4,672
Thereafter	8,082
Total lease payments	37,251
Less: imputed interest	(7,287)
Present value of operating lease liabilities	$ 29,964

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Leases [Abstract]
2022	$ 6,954
2023	6,790
2024	6,642
2025	5,976
2026	3,579
Thereafter	4,304
Total minimum future payments	$ 34,245

Commitment and Contingencies (D

Commitment and Contingencies (Details) $ in Millions	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Contractual commitments	$ 113.1

Stockholders' Equity and Stoc_3

Stockholders' Equity and Stock Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands		1 Months Ended			3 Months Ended		9 Months Ended
	Feb. 14, 2022 shares	Sep. 30, 2022 $ / shares shares	Sep. 30, 2021 USD ($) tranche target $ / shares shares	May 31, 2019 shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) purchasePeriod $ / shares shares	Sep. 30, 2021 USD ($)	Aug. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)		104,218,000			104,218,000		104,218,000
Stock options granted (in shares)							1,816,000
Issuance of common stock under employee stock purchase plan, net of shares withheld for taxes (in shares)							510,093
Proceeds from issuance of common stock under employee stock purchase plan, net | $							$ 7,011	$ 0
Share-based payment arrangement, expensed and capitalized, amount | $					$ 53,944	$ 124,717	$ 151,927	124,717
Weighted-average grant date fair value of stock options granted (in USD per share) | $ / shares					$ 8.26		$ 8.26
Stock withheld for tax withholding requirements (in shares)					1,000,000		8,600,000
Restricted stock issued net of shares withheld for taxes (in shares)	9,300,000
Cash paid related to withholding taxes on share settlement of equity awards | $							$ 151,716	0
Stock-based compensation, net of amounts capitalized | $					$ 53,892	124,259	$ 150,652	124,259
2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)		6,491,000			6,491,000		6,491,000		10,000,000
2022 Inducement Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		25%
2022 Inducement Plan | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		75%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)		8,698,000			8,698,000		8,698,000
Offering period							24 months
Number of purchase periods | purchasePeriod							4
Purchase period							6 months
Share-based compensation arrangement by share-based payment award, weighted average price of shares purchased (in USD per share) | $ / shares		$ 13.76			$ 13.76		$ 13.76
Proceeds from issuance of common stock under employee stock purchase plan, net | $							$ 7,000
ESPP offering period							24 months
Share-based payment arrangement, expensed and capitalized, amount | $					$ 2,200		$ 9,400
Dividend yield							0%
ESPP | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price volatility expected term		1 year			1 year		1 year
ESPP | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock price volatility expected term		2 years			2 years		2 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period							4 years
Dividend yield							0%
Contractual term							10 years
Stock options | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Stock options | 2022 Inducement Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		1 year
Stock options | President | Inducement Plan and 2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)		1,815,980
Stock options | President | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)		1,776,780
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares approved for grant (in shares)							12,048,000
Award vesting period							4 years
Total restricted stock units vested (in shares)					2,600,000		21,568,000
Cash paid related to withholding taxes on share settlement of equity awards | $					$ 13,400		$ 151,700
Restricted Stock Units | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Restricted Stock Units | 2022 Inducement Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		1 year
Restricted Stock Units | President | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares approved for grant (in shares)		1,732,501
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares approved for grant (in shares)			6,000,000	166,390
Number of threshold stock price targets | target			5
Number of threshold vesting tranches | tranche			5
Trading day period			60 days
Total grant date fair value | $			$ 131,000
Stock-based compensation, net of amounts capitalized | $					$ 7,100	$ 1,400	$ 21,000	$ 1,400
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares			$ 70
Performance Based Restricted Stock Units (PRSUs) | Chief Executive Officer | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold stock price target (in USD per share) | $ / shares			$ 200
Class A Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock in percent							85%

Stockholders' Equity and Stoc_4

Stockholders' Equity and Stock Based Compensation - Shares of Common Stock Reserved for Future Issuance (Details) - shares	Sep. 30, 2022	Aug. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	104,218,000
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	8,698,000
2011 Stock Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	25,057,000
2021 Equity Incentive Plan:
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	50,477,000
2021 Equity Incentive Plan: | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	9,986,000
2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	6,491,000	10,000,000
2022 Inducement Plan | Share-Based Payment Arrangements
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for issuance (in shares)	3,509,000

Stockholders' Equity and Stoc_5

Stockholders' Equity and Stock Based Compensation - Summary of ESPP Valuation Assumptions (Details)	9 Months Ended
	Sep. 30, 2022
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0%
ESPP | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months
Stock price volatility	55.80%
Risk-free interest rate	1.54%
ESPP | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years
Stock price volatility	84.50%
Risk-free interest rate	2.58%
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years 1 month 6 days
Stock price volatility	65%
Risk-free interest rate	3.37%
Dividend yield	0%

Stockholders' Equity and Stoc_6

Stockholders' Equity and Stock Based Compensation - Summary of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Number of Shares
Beginning balance (in shares)	1,348
Stock options granted (in shares)	1,816
Stock options exercised (in shares)	(383)
Stock options cancelled / forfeited / expired (in shares)	0
Ending balance (in shares)	2,781	1,348
Options vested or expected to vest (in shares)	2,781
Options exercisable (in shares)	965
Weighted-Average Exercise Price
Beginning balance (in USD per share)	$ 0.27
Stock options granted (in USD per share)	13.61
Stock options exercised (in USD per share)	0.27
Stock options cancelled / forfeited / expired (in USD per share)	0
Ending balance (in USD per share)	8.98	$ 0.27
Options vested or expected to vest (in USD per share)	8.98
Options exercisable (in USD per share)	$ 0.27
Weighted-Average Remaining Contractual Term (in years)
Weighted-Average Remaining Contractual Term (in years)	7 years 6 months	3 years 7 months 6 days
Options vested or expected to vest as of the end of the period	7 years 6 months
Options exercisable as of the end of the period	2 years 10 months 24 days
Aggregate Intrinsic Value
Aggregate intrinsic value	$ 12,260	$ 35,020
Options vested or expected to vest as of the end of the period	12,260
Options exercisable as of the end of the period	$ 12,260

Stockholders' Equity and Stoc_7

Stockholders' Equity and Stock Based Compensation - Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units - $ / shares shares in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Number of Shares
Unvested, beginning balance (in shares)		47,830
Granted (in shares)		12,048
Vested (in shares)	(2,600)	(21,568)
Forfeited (in shares)		(2,539)
Unvested, ending balance (in shares)	35,771	35,771
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in USD per share)		$ 14.47
Granted (in USD per share)		17.19
Vested (in USD per share)		8.88
Forfeited (in USD per share)		16.54
Unvested, ending balance (in USD per share)	$ 18.60	$ 18.60

Stockholders' Equity and Stoc_8

Stockholders' Equity and Stock Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 53,892	$ 124,259	$ 150,652	$ 124,259
Capitalized stock-based compensation	52	458	1,275	458
Total stock-based compensation expense	53,944	124,717	151,927	124,717
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	1,772	3,983	5,212	3,983
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	10,318	36,823	26,446	36,823
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	16,635	40,465	44,204	40,465
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	25,167	42,988	74,790	42,988
General and administrative | RSUs and PRSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation, net of amounts capitalized	$ 14,100	$ 10,400	$ 41,800	$ 10,400

Stockholders' Equity and Stoc_9

Stockholders' Equity and Stock Based Compensation - Schedule of Unrecognized Stock-Based Compensation (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, including options	$ 14,702
Total unrecognized stock-based compensation expense	623,230
RSUs and PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 596,666
Weighted-Average Period to Recognize Expense (in years)	3 years 1 month 6 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Period to Recognize Expense (in years)	3 years 10 months 24 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense, excluding options	$ 11,862
Weighted-Average Period to Recognize Expense (in years)	1 year

Stockholders' Equity and Sto_10

Stockholders' Equity and Stock Based Compensation - Phantom (Details)	1 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Restricted Stock Units | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Restricted Stock Units | 2022 Inducement Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		4 years
Stock options | 2022 Inducement Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Stock options | 2022 Inducement Plan | Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	1 year

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss	$ (57,843)	$ (107,415)	$ (176,655)	$ (117,259)
Accretion of redeemable convertible preferred stock	0	2,264,838	0	2,646,662
Net income (loss) available to common stockholders, basic, total	(57,843)	(2,372,253)	(176,655)	(2,763,921)
Net income (loss) available to common stockholders, diluted, total	$ (57,843)	$ (2,372,253)	$ (176,655)	$ (2,763,921)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders - basic (in shares)	286,697	95,930	283,258	83,860
Weighted-average shares used in computing net loss per share attributable to common stockholders - diluted (in shares)	286,697	95,930	283,258	83,860
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)	$ (0.20)	$ (24.72)	$ (0.62)	$ (32.96)
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)	$ (0.20)	$ (24.72)	$ (0.62)	$ (32.96)

Net Loss Per Share - Potential

Net Loss Per Share - Potential Common Equivalents Excluded from Computation of Diluted Net Loss per Share (Details) - shares shares in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	38,911	60,318
RSUs and PRSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	35,771	58,636
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,781	1,682
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	359	0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 1,804	$ (9,915)	$ 6,500	$ (7,720)
Effective income tax, other reconciling items, amount	$ 11,700

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 128,760	$ 96,614	$ 364,829	$ 265,542
Total long-lived assets	52,202		52,202		$ 23,373
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	56,288	41,961	157,178	113,668
Total long-lived assets	21,364		21,364		13,780
Europe, Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	49,786	39,566	143,169	110,695
Total long-lived assets	4,358		4,358		578
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	19,296	12,955	55,015	35,382
Total long-lived assets	26,480		26,480		$ 9,015
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,390	$ 2,132	$ 9,467	$ 5,797